Vitura Health Limited (ASX:VIT)
Australia
· Delayed Price · Currency is AUD 0.0690
+0.0010 (1.47%)
Apr 24, 2025, 1:31 PM AEST
Vitura Health Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2017 - 2019 |
| Operating Revenue | 126.57 | 123.87 | 117.34 | 66.99 | 21.71 | 0.12 | Upgrade
|
| Revenue | 126.57 | 123.87 | 117.34 | 66.99 | 21.71 | 0.12 | Upgrade
|
| Revenue Growth (YoY) | 5.77% | 5.56% | 75.16% | 208.54% | 17431.02% | - | Upgrade
|
| Cost of Revenue | 93.11 | 89.65 | 77.65 | 41.56 | 15.06 | 0.01 | Upgrade
|
| Gross Profit | 33.46 | 34.22 | 39.69 | 25.43 | 6.66 | 0.12 | Upgrade
|
| Selling, General & Admin | 30.41 | 29.35 | 19.83 | 15.51 | 4.96 | 4.24 | Upgrade
|
| Operating Expenses | 30.41 | 29.35 | 19.83 | 15.51 | 4.96 | 4.24 | Upgrade
|
| Operating Income | 3.05 | 4.87 | 19.86 | 9.92 | 1.7 | -4.12 | Upgrade
|
| Interest Expense | -0.87 | -0.65 | -0.03 | -0.06 | -0.03 | -0.21 | Upgrade
|
| Interest & Investment Income | 0.58 | 0.67 | 0.33 | 0.01 | 0 | 0.13 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.11 | -0.18 | -0.06 | -0.2 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.19 | -0.15 | -0.06 | -0.15 | 0.13 | - | Upgrade
|
| EBT Excluding Unusual Items | 2.45 | 4.56 | 20.04 | 9.52 | 1.8 | -4.2 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.02 | - | 0.01 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0 | 0 | 0.01 | 0.22 | - | 0.02 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.08 | 0.19 | Upgrade
|
| Pretax Income | 2.43 | 4.56 | 20.05 | 9.74 | 1.89 | -3.99 | Upgrade
|
| Income Tax Expense | 0.73 | 1.31 | 6.3 | 3.73 | 0.47 | - | Upgrade
|
| Earnings From Continuing Operations | 1.71 | 3.25 | 13.75 | 6.01 | 1.42 | -3.99 | Upgrade
|
| Minority Interest in Earnings | 0.24 | 0.26 | 0.06 | 0.04 | - | 0.05 | Upgrade
|
| Net Income | 1.95 | 3.51 | 13.81 | 6.05 | 1.42 | -3.94 | Upgrade
|
| Net Income to Common | 1.95 | 3.51 | 13.81 | 6.05 | 1.42 | -3.94 | Upgrade
|
| Net Income Growth | -79.30% | -74.56% | 128.31% | 326.72% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 577 | 570 | 555 | 482 | 402 | 92 | Upgrade
|
| Shares Outstanding (Diluted) | 577 | 570 | 572 | 487 | 402 | 92 | Upgrade
|
| Shares Change (YoY) | 1.13% | -0.33% | 17.44% | 21.21% | 337.86% | 2933.06% | Upgrade
|
| EPS (Basic) | 0.00 | 0.01 | 0.02 | 0.01 | 0.00 | -0.04 | Upgrade
|
| EPS (Diluted) | 0.00 | 0.01 | 0.02 | 0.01 | 0.00 | -0.04 | Upgrade
|
| EPS Growth | -80.06% | -74.54% | 95.15% | 254.39% | - | - | Upgrade
|
| Free Cash Flow | -0.13 | 6.67 | 8.78 | 13.14 | 0.89 | -5 | Upgrade
|
| Free Cash Flow Per Share | - | 0.01 | 0.01 | 0.03 | 0.00 | -0.05 | Upgrade
|
| Dividend Per Share | - | - | 0.010 | 0.010 | - | - | Upgrade
|
| Gross Margin | 26.44% | 27.63% | 33.82% | 37.96% | 30.65% | 94.30% | Upgrade
|
| Operating Margin | 2.41% | 3.93% | 16.93% | 14.81% | 7.83% | -3330.34% | Upgrade
|
| Profit Margin | 1.54% | 2.84% | 11.77% | 9.03% | 6.53% | -3179.02% | Upgrade
|
| Free Cash Flow Margin | -0.10% | 5.38% | 7.48% | 19.61% | 4.11% | -4036.16% | Upgrade
|
| EBITDA | 3.01 | 5.28 | 20.22 | 10.12 | 1.78 | -4.1 | Upgrade
|
| EBITDA Margin | 2.38% | 4.26% | 17.23% | 15.11% | 8.21% | - | Upgrade
|
| D&A For EBITDA | -0.04 | 0.41 | 0.36 | 0.2 | 0.08 | 0.03 | Upgrade
|
| EBIT | 3.05 | 4.87 | 19.86 | 9.92 | 1.7 | -4.12 | Upgrade
|
| EBIT Margin | 2.41% | 3.93% | 16.93% | 14.81% | 7.83% | - | Upgrade
|
| Effective Tax Rate | 29.81% | 28.79% | 31.44% | 38.30% | 24.91% | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.